Incannex Healthcare (IXHL) Interest Coverage Ratio (2023 - 2026)
Incannex Healthcare (IXHL) posted quarterly Interest Coverage Ratio of 32.91 for Q1 2026, down 109.19% year-on-year from 358.28 in Q1 2025, and up 17.19% on a QoQ basis from 39.74 in Q4 2025.
Incannex Healthcare (IXHL) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Interest Coverage Ratio for 4 consecutive years, with 32.91 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio fell 109.19% year-over-year to 32.91 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 206.22 (down 152.17% YoY) and the FY2025 annual result came in at 78.51, down 44851.86% from the prior year.
- Interest Coverage Ratio improved to 32.91 in Q1 2026 per IXHL's latest filing, from 39.74 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for IXHL reached as high as 0.06 in Q2 2024 and fell as low as 39.74 in Q4 2025.
- A 4-year average of 19.27 and a median of 13.89 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio jumped 99.8% — and 2025, when it plunged 188.31%.
- Year by year, Interest Coverage Ratio stood at 13.11 in 2023, then retreated by 5.16% to 13.79 in 2024, then sank by 188.31% to 39.74 in 2025, then advanced by 17.19% to 32.91 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 32.91, 39.74, and 29.93 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | -32.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.91 |
| Dec 31, 2025 | -39.74 |
| Sep 30, 2025 | -29.93 |
| Mar 31, 2025 | -15.73 |
| Dec 31, 2024 | -13.79 |
| Sep 30, 2024 | -13.66 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -13.89 |
| Dec 31, 2023 | -13.11 |
| Sep 30, 2023 | -11.07 |
| Jun 30, 2023 | -28.15 |